Literature DB >> 6449154

Development of Crotalaria pulmonary hypertension: hemodynamic and structural study.

B Meyrick, W Gamble, L Reid.   

Abstract

In awake rats with indwelling catheters, the development of pulmonary hypertension after feeding Crotalaria spectabilis seeds is followed. Hypoxemia is excluded as a factor. Other hemodynamic changes are found before hypertension. After 7 days, pulmonary artery pressure (Ppa) is normal, 17.17 +/- 0.30 (SE) mmHg and from 14 days significantly increased (P < 0.01). Oxygen consumption (Vo2) is significantly increased by day 7 (control 22.72 +/- 2.13 ml . min-1 . kg-1; Crotalaria 42.47 +/- 2.95; P < 0.001). and cardiac index (CI) is significantly above normal after 7, 14, and 21 days (control 350 +/- 31 ml . min-1 . kg-1; 7 days Crotalaria 476 +/- 28; P < 0.02); pulmonary vascular resistance (PVR) increases to six times normal at day 33 (control 0.033 +/- 0.003 U/kg; 33 days Crotalaria 0.194 +/- 0.020; P < 0.001). The pulmonary arteries of these same rats were studied by quantitative morphometric techniques. The first change, muscle in smaller and more peripheral arteries than normal, is detected when Vo2 and CI are increased. Increased medial thickness of arteries < 200 micrometer diameter follows with Ppa rises. Even later, the larger arteries increase their media as the number of peripheral arteries falls and right ventricular hypertrophy becomes apparent, and hypertension and increased PVR are well established.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449154     DOI: 10.1152/ajpheart.1980.239.5.H692

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  50 in total

1.  Rhythmical contractions in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.

Authors:  Akihiko Kiyoshi; Tomohisa Ishikawa; Ken-ichi Hayashi; Yoshiyuki Iwatsuki; Kunio Ishii; Koichi Nakayama
Journal:  Pflugers Arch       Date:  2003-09-27       Impact factor: 3.657

2.  Simultaneous pulmonary and systemic blood pressure and ECG Interval measurement in conscious, freely moving rats.

Authors:  Markus Rey; Edgar W Weber; Patrick D Hess
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

Review 3.  Micro-computed tomography of the lungs and pulmonary-vascular system.

Authors:  Erik L Ritman
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

5.  Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension.

Authors:  A Zimmer; R B Teixeira; J H P Bonetto; R Siqueira; C C Carraro; L M Donatti; A Hickmann; I E Litvin; A E G Godoy; A S Araujo; R Colombo; Adriane Belló-Klein
Journal:  Mol Cell Biochem       Date:  2017-02-08       Impact factor: 3.396

6.  Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.

Authors:  K Ito; K Hayashi; T Nakashima; T Murakami
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

7.  A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model.

Authors:  Juha W Koskenvuo; Rachel Mirsky; Yan Zhang; Franca S Angeli; Sarah Jahn; Tero-Pekka Alastalo; Nelson B Schiller; Andrew J Boyle; Kanu Chatterjee; Teresa De Marco; Yerem Yeghiazarians
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-07       Impact factor: 2.357

8.  Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.

Authors:  T Takahashi; T Kanda; S Imai; T Suzuki; I Kobayashi; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

9.  Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.

Authors:  J M Kay; K L Suyama; P M Keane
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

Review 10.  Vascular remodeling in pulmonary hypertension.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Mol Med (Berl)       Date:  2013-01-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.